Olivier FAHY, Chairman and Chief Executive Officer of Groupe Berkem, commented: “Our revenue growth in 2021 is a result of the acceleration in our activity both in France and abroad in response to the ever-increasing demand for bio-sourced chemical solutions in everyday products. In order to achieve our industrial, commercial and innovation objectives, we have accelerated recruitments and strengthened our investment ability notably thanks to our very successful IPO on the Euronext Growth market in Paris. Armed with these assets, we are able to reaffirm our profitability target with an EBITDA margin of 25% and organic revenue of €65 million by 2024”.
